DarioHealth (DRIO) Return on Sales (2014 - 2026)

DarioHealth's Return on Sales history runs 13 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 1.0% YoY) and the FY2025 annual result came in at 0.02%, down 1.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at DarioHealth, up from 0.02% in the prior quarter.
• Across five years, Return on Sales topped out at 0.06% in Q4 2023 and bottomed at 0.04% in Q3 2023.
• A 5-year average of 0.01% and a median of 0.02% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales dropped 7 bps — and 2023, when it advanced 8 bps.
• DarioHealth's Return on Sales stood at 0.02% in 2022, then jumped by 445 bps to 0.06% in 2023, then sank by 82 bps to 0.01% in 2024, then sank by 259 bps to 0.02% in 2025, then grew by 14 bps to 0.01% in 2026.
• Business Quant data shows DRIO's Return on Sales at 0.01% in Q1 2026, 0.02% in Q4 2025, and 0.02% in Q3 2025.